Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07224789

Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA

Conditions: Colorectal Cancer

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: Yes

Enrollment: 600

Sponsor: City of Hope Medical Center

Location: City of Hope Medical Center Duarte California

Summary

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.

Eligibility Criteria

Inclusion Criteria: * Adults (≥18 years old) * Histologically confirmed colorectal cancer (Stage I-III) * Availability of pre-treatment plasma samples * Written informed consent provided Exclusion Criteria: * History of other active malignancies within the past 5 years * Poor sample quality or hemolysis * Inability to provide informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07224789). StuddyBuddy aggregates publicly available trial information.